awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50053733-5F540107-3EAF-4A8A-8407-A4354F514BAB
Q50053733-5F540107-3EAF-4A8A-8407-A4354F514BAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50053733-5F540107-3EAF-4A8A-8407-A4354F514BAB
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab.
P2860
Q50053733-5F540107-3EAF-4A8A-8407-A4354F514BAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50053733-5F540107-3EAF-4A8A-8407-A4354F514BAB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6c22f35d4c4e62ed7498f7f60eb13250eb73120
P2860
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study